Stock Report

Download full stock data and analysis for free Last Updated: 30-Aug-2026

Stock Rating

See the stock’s health at a glance, before it's too late.

Wealth Insight New Issue

This month’s issue could change how you invest, read now.

Recently Viewed

Clear All

Aptus Pharma Key Ratios

Stock Card factsheet watchlist-stock-modal share-fund-plan-icon

BSE: 544529

₹320.70

up-down-arrow ₹6.25 (1.99%)

As on 28-Aug-2026IST

Market cap

info icon

₹550 Cr

Revenue (TTM)

info icon

₹47 Cr

P/E Ratio

info icon

119.1

P/B Ratio

info icon

16.4

Div. Yield

info icon

0 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue -- -- 89.65 49.65 --
EBIT -- -- 53.71 152.36 --
Net Profit -- -- 49.05 187.55 --
EPS -- -- 443.21 73.24 --
Book Value -- -- 1,121.33 74.04 --
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsMar-26Mar-25Mar-24
EBIT-Margin info 13.75--15.1318.677.46
Net Margin info 8.98--9.8912.584.46
Return on equity info 53.28--30.4870.9958.36
Return on Capital info 31.57--30.0138.2226.47
Return on Assets info 14.51--14.1519.489.88
Debt to Equity (x) info ----0.311.493.00

Profitability

View Detailed Peer Comparison

ROCE

30.01

Higher than Peers by 14.26

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Aptus Pharma
30.01
38.22
26.47
13.79
--
Peer Median
15.74
14.72
18.85
11.60
--
ROE

30.48

Higher than Peers by 16.74

Profit after tax / Average Net worth * 100

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Aptus Pharma
30.48
70.99
58.36
20.06
--
Peer Median
13.75
11.67
14.92
11.46
--
ROA

14.15

Higher than Peers by 5.98

Profit after tax / Average Total assets * 100

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Aptus Pharma
14.15
19.48
9.88
3.14
--
Peer Median
8.17
7.86
9.06
6.44
--
EBIT Margin

15.13

Higher than Peers by 0.35

Operating profit (EBIT) / Net Sales * 100

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Aptus Pharma
15.13
18.67
7.46
3.15
--
Peer Median
14.78
15.03
14.71
12.37
--
Net Margin

9.89

Higher than Peers by 1.35

Net profit / Total Income (Net sales plus other income) * 100

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Aptus Pharma
9.89
12.58
4.46
1.40
--
Peer Median
8.54
9.33
8.49
10.02
--
Cash Profit Margin

10.51

--

(Net profit + Depreciation) / Gross Sales * 100

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Aptus Pharma
10.51
13.49
5.64
2.67
--
Peer Median
--
--
--
--
--

Growth

View Detailed Peer Comparison

Revenue Growth

89.65

Higher than Peers by 75.54

Year on year growth in net sales

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Aptus Pharma
89.65
37.52
28.49
--
--
Peer Median
14.12
10.27
11.85
9.08
--
EBIT Growth

53.71

Higher than Peers by 32.12

Year on year growth in operating profit (EBIT)

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Aptus Pharma
53.71
244.14
203.83
--
--
Peer Median
21.59
24.15
28.00
-3.12
--
Net Profit Growth

49.05

Higher than Peers by 20.74

Year on year growth in profit after tax

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Aptus Pharma
49.05
288.37
310.76
--
--
Peer Median
28.31
30.29
36.51
-0.85
--
EPS Growth

443.21

Higher than Peers by 428.96

Year on year growth in earnings per share

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Aptus Pharma
443.21
-76.70
310.76
--
--
Peer Median
14.25
24.50
--
-6.82
--
Book Value Growth

235.14

--

Year on year growth in book value per share

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Aptus Pharma
235.14
294.34
82.41
--
--
Peer Median
--
--
--
--
--

Solvency

View Detailed Peer Comparison

Debt to Equity

0.31

Higher than Peers by 0.11

Total debt / Net worth

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Aptus Pharma
0.31
1.49
3.00
2.28
--
Peer Median
0.20
0.23
0.20
0.15
--
Short term debt to equity ratio

0.28

--

(Short term borrowings / Net worth)

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Aptus Pharma
0.28
0.95
0.56
--
--
Peer Median
--
--
--
--
--
Current Ratio

1.83

Lower than Peers by 0.01

Current Assets / Current Liabilities and Provisions

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Aptus Pharma
1.83
1.63
2.01
1.81
--
Peer Median
1.83
1.79
1.96
2.08
--
Quick Ratio

1.12

Lower than Peers by 0.11

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Aptus Pharma
1.12
1.05
1.18
1.07
--
Peer Median
1.23
1.47
1.44
1.58
--
Interest Coverage

8.92

Higher than Peers by 0.51

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Aptus Pharma
8.92
9.97
5.67
3.06
--
Peer Median
8.41
9.42
8.58
15.41
--

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

40.28

Higher than Peers by 14.99

Debtors outstanding / Net Sales * 100

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Aptus Pharma
40.28
22.96
18.78
17.26
--
Peer Median
25.29
25.82
26.12
22.96
--
Asset Turnover

1.47

Higher than Peers by 0.73

Sales / Average Total Assets

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Aptus Pharma
1.47
1.57
2.23
2.28
--
Peer Median
0.73
0.75
0.77
0.65
--
Receivable days

93.10

--

Average Debtors / Sales * 365

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Aptus Pharma
93.10
65.80
58.41
62.23
--
Peer Median
--
--
--
--
--
Inventory Days

78.71

--

Average Inventory / Sales * 365

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Aptus Pharma
78.71
76.71
58.13
59.65
--
Peer Median
--
--
--
--
--
Payable days

80.80

--

Average Creditors / Cost of goods sold * 365

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Aptus Pharma
80.80
53.78
72.69
104.57
--
Peer Median
--
--
--
--
--
Cash Conversion Cycle

91.00

--

Receivable Days + Inventory Days - Payable Days

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Aptus Pharma
91.00
88.73
43.86
17.31
--
Peer Median
--
--
--
--
--

Valuation

View Detailed Peer Comparison

Price / Earnings

20.74

Lower than Peers by 19.16

Current share price divided by earning per share in the last twelve months

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Aptus Pharma
20.74
--
--
--
--
Peer Median
39.90
39.70
33.48
37.74
--
Price / Book Value

10.26

Higher than Peers by 6.00

Current share price divided by book value per share in the latest financial year

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Aptus Pharma
10.26
--
--
--
--
Peer Median
4.26
3.72
4.21
3.22
--
Dividend Yield

--

--

Dividend per share in the past twelve months divided by current share price

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Aptus Pharma
--
--
--
--
--
Peer Median
0.10
0.16
0.21
0.57
--
EV/EBITDA

32.38

Higher than Peers by 3.67

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Aptus Pharma
32.38
2.06
2.99
3.19
--
Peer Median
28.71
30.23
29.90
28.81
--
Market Cap

240

Lower than Peers by 5,797

Current Share price multiplied by latest total number of shares outstanding

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Aptus Pharma
240
--
--
--
--
Peer Median
6,036
4,851
2,099
15,272
--
loading...
loading...
loading...